Answer
Rifinah (isoniazid + rifampicin) strongly induces CYP2C19, increasing clopidogrel’s active metabolite levels and platelet inhibition, which may increase bleeding risk; concomitant use is discouraged as a precaution.
Sources for this answer
- Rifinah 150mg/100mg TabletsSANOFI · emc · SmPC §4.5 Interaction with other medicinal products · Version 26Document updated
Sources checked